Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry

Trend of microbiologically-confirmed tuberculosis in a low-incidence setting with high immigration rates

(2014) Giulia Lombardi et al.   BMC PUBLIC HEALTH

Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy

(2014) P. Gisondi et al.   BRITISH JOURNAL OF DERMATOLOGY

Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists:in vivoandin vitroanalysis

(2013) I. Sauzullo et al.   BRITISH JOURNAL OF DERMATOLOGY

Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers

(2013) Rosita Saraceno et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: Results of a nationwide cohort study from Taiwan

(2013) Yi-Ju Chen et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Evaluating the use of the interferon-γ response toMycobacterium tuberculosis-specific antigens in patients with psoriasis prior to antitumour necrosis factor-α therapy: a prospective head-to-head cross-sectional study

(2012) C.L. Martyn-Simmons et al.   BRITISH JOURNAL OF DERMATOLOGY

Mycobacterial Interferon-  Release Variations During Longterm Treatment with Tumor Necrosis Factor Blockers: Lack of Correlation with Clinical Outcome

(2012) R. SCRIVO et al.   JOURNAL OF RHEUMATOLOGY

Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry

(2012) A.I. Sánchez-Moya et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry

(2012) P. Gisondi et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Latent Tuberculosis Infection in the United States

(2011) C. Robert Horsburgh et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tuberculosis infection in rheumatic patients with infliximab therapy: experience with 157 patients

(2011) Christiane Aguiar Nobre et al.   RHEUMATOLOGY INTERNATIONAL

The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement

(2010) I. Solovic et al.   EUROPEAN RESPIRATORY JOURNAL

Incidence of tuberculosis infection in psoriatic patients on anti-TNF therapy: report of a case series with 144 patients

(2010) AI Sánchez-Moya et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Tuberculin Skin Test Overestimates Tuberculosis Hypersensitivity in Adult Patients with Psoriasis

(2009) G. Tsiouri et al.   DERMATOLOGY

Guidelines of care for the management of psoriasis and psoriatic arthritis

(2009) Alan Menter et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

European S3-Guidelines on the systemic treatment of psoriasis vulgaris

(2009) D Pathirana et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Tuberculosis in liver transplant recipients: A systematic review and meta-analysis of individual patient data

(2009) Jon-Erik C. Holty et al.   LIVER TRANSPLANTATION

Comparative Performance of Tuberculin Skin Test, QuantiFERON-TB-Gold In Tube Assay, and T-Spot. TB Test in Contact Investigations for Tuberculosis

(2008) Roland Diel et al.   CHEST

Psocare: Italy Shows the Way in Postmarketing Studies

(2008) Tamar Nijsten et al.   DERMATOLOGY

National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents

(2008) Sean D. Doherty et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY